Apotex Says Mylan, Ranbaxy Rewrite Law In Provigil Appeal
Apotex told the Third Circuit on Monday that Mylan and Ranbaxy have misrepresented the standard for holding both companies fully responsible for competitive harm in pay-for-delay class litigation over the narcolepsy...To view the full article, register now.
Already a subscriber? Click here to view full article